.Pharmacolibrary.Drugs.C_CardiovascularSystem.C07A_BetaBlockingAgents.C07AB03_Atenolol.Atenolol

Information

name:Atenolol
ATC code:C07AB03
route:oral
n-compartments1

Atenolol is a cardioselective beta-1 adrenergic blocker used primarily to treat hypertension, angina pectoris, and acute myocardial infarction. It is widely approved and utilized as an antihypertensive and antianginal agent.

Pharmacokinetics

Pharmacokinetic parameters in healthy adult volunteers following oral administration.

References

  1. McCormack, PL, & Wagstaff, AJ (2003). Lacidipine: a review of its use in the management of hypertension. Drugs 63(21) 2327–2356. DOI:10.2165/00003495-200363210-00008 PUBMED:https://pubmed.ncbi.nlm.nih.gov/14524737

  2. Hurst, AK, et al., & Elkayam, U (1998). Pharmacokinetic and pharmacodynamic evaluation of atenolol during and after pregnancy. Pharmacotherapy 18(4) 840–846. PUBMED:https://pubmed.ncbi.nlm.nih.gov/9692658

  3. Ali, O, et al., & Ahmed, SW (2005). Biopharmaceutical evaluation of oral tablet Atenolol (100 and 50 mg) on local population. Pakistan journal of pharmaceutical sciences 18(1) 25–32. PUBMED:https://pubmed.ncbi.nlm.nih.gov/16431379

Revisions

Generated at 2025-07-21T18:21:10Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos